Gemcitabine Plus Cisplatin Versus Non-Gemcitabine and Cisplatin Regimens as Neoadjuvant Treatment for Cholangiocarcinoma Patients Prior to Liver Transplantation: An Institution Experience

BACKGROUND: Cholangiocarcinoma management is constantly being updated in view of existing evidence in order to establish practice guidelines and consensus statements. However, the available treatment guidelines to optimize outcomes for cholangiocarcinoma patients who require liver transplantation ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelrahim, Maen, Esmail, Abdullah, Xu, Jiaqiong, Umoru, Godsfavour, Al-Rawi, Hadeel, Saharia, Ashish, Abudayyeh, Ala, Victor, David, McMillan, Robert, Kodali, Sudha, Ghobrial, Rafik M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201492/
https://www.ncbi.nlm.nih.gov/pubmed/35719974
http://dx.doi.org/10.3389/fonc.2022.908687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201492/
https://www.ncbi.nlm.nih.gov/pubmed/35719974
http://dx.doi.org/10.3389/fonc.2022.908687

Ejemplares similares